Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

STAG2 and Mullegama-Klein-Martinez Syndrome

Mullegama-Klein-Martinez syndrome (MKMS) is a rare X-linked cohesinopathy caused by heterozygous loss-of-function variants in the STAG2 gene. Two unrelated female probands with de novo STAG2 LoF variants—a frameshift c.3458_3459del (p.Arg1033ThrfsTer22) (PMID:35887945) and a splice-site c.1196+4_1196+7del (PMID:40456439)—presented with severe intellectual disability, microcephaly, short stature, and central diabetes insipidus, confirming a consistent phenotype across cases.

STAG2 escapes X-inactivation, indicating a dosage-sensitive haploinsufficiency mechanism for LoF alleles. Clinical exome sequencing is therefore recommended for female patients with syndromic developmental delay and endocrine anomalies to enable early diagnosis and management. Key take-home: De novo STAG2 LoF variants should be considered in females with MKMS phenotypes for precise genetic counseling.

References

  • European journal of medical genetics • 2025 • Novel STAG2 variant expands Mullegama-Klein-Martinez Syndrome phenotype. PMID:40456439
  • Journal of clinical medicine • 2022 • Non-Invasive Detection of a De Novo Frameshift Variant of STAG2 in a Female Fetus: Escape Genes Influence the Manifestation of X-Linked Diseases in Females. PMID:35887945

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Two unrelated probands with de novo LoF variants and consistent phenotype

Genetic Evidence

Limited

Two de novo STAG2 loss-of-function variants in unrelated female cases with MKMS, no segregation

Functional Evidence

Limited

Evidence of STAG2 escape from X-inactivation supports a haploinsufficiency mechanism